巨GH:导致诊断挑战的临床实体——一例病例报告
本文报告一例61岁女性垂体大腺瘤伴生长激素升高病例,实验室检查显示空腹GH升高(夹心化学发光免疫分析法LIAISON® XL测定),口服葡萄糖耐量试验无抑制,IGF-1正常,无肢端肥大症典型症状。经蝶窦手术后GH仍升高,怀疑免疫测定干扰,用三种不同免疫测定法分析GH,25%聚乙二醇沉淀后GH回收率为12%,尺寸排阻色谱法证实血清中存在巨GH。结论:当实验室结果与临床表现不一致时,应怀疑免疫化学测定中存在干扰,可采用PEG法和尺寸排阻色谱法识别巨GH引起的干扰。
要点
- 当GH升高但无肢端肥大症临床表现且IGF-1正常时,应怀疑巨GH干扰。
- PEG沉淀后GH回收率低(本例12%)提示巨GH可能。
- 尺寸排阻色谱法可证实巨GH的存在。
核心结论
- 当实验室结果与临床表现不一致时,应怀疑免疫测定中存在干扰,巨GH是可能原因之一。
- 可采用PEG法和尺寸排阻色谱法识别巨GH引起的干扰。
研究设计与样本
- 病例报告:一例61岁女性垂体大腺瘤伴GH升高患者。
主要发现
- 空腹GH升高(LIAISON® XL夹心化学发光免疫分析法),口服葡萄糖耐量试验无抑制,IGF-1正常,无肢端肥大症典型症状。
- 经蝶窦手术后GH仍升高,怀疑测定干扰。
- 三种免疫测定法(UniCel DxI 600、Cobas e411、hGH-IRMA)分析GH,血清中未检测到异嗜性抗体和类风湿因子。
- 25% PEG沉淀后GH回收率为12%。
- 尺寸排阻色谱法证实血清中存在巨GH。
临床怎么用
- 对临床表现与GH测定结果不符的患者,应考虑巨GH干扰可能。
- 采用PEG沉淀法和尺寸排阻色谱法进行验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Presentation of a new case of a patient with macro-GH, that may interfere with different GH assays leading to false-positive results in serum samples. CASE PRESENTATION: A 61-year-old female was referred with a pituitary macroadenoma and elevated growth hormone levels. The laboratory tests showed increased fasting GH level, measured by a sandwich chemiluminescence immunoassay (LIAISON® XL) without suppression on oral glucose tolerance test and normal IGF-1. The patient did not have the typical signs and symptoms of acromegaly. The patient underwent a transsphenoidal resection of a pituitary tumor, showing only α-subunit immunostaining. Postoperative GH levels remained elevated. An interference in the determination of GH level was suspected. GH was analyzed by three different immunoassays, UniCel DxI 600, Cobas e411 and hGH-IRMA. Heterophilic antibodies and rheumatoid factor were not detected in serum sample. GH recovery after precipitation with 25 % polyethylene glycol (PEG) was 12 %. Size-exclusion chromatography confirmed the presence of macro-GH in serum sample. CONCLUSION: If results of laboratory tests are not consistent with the clinical findings, the presence of an interference within immunochemical assays could be suspected. To identify interference caused by the macro-GH, the PEG method and size-exclusion chromatography should be used.
引用
- Stelmachowska-Banaś M, Ostrowska M, Goszczyński TM, et al. Macro-GH - A clinical entity causing a diagnostic challenge - A case report. Clin Chim Acta. 2023. PMID: 37187223. doi:10.1016/j.cca.2023.117392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。